30 Day Trial

Xtant Medical Reports Preliminary 4Q15 and 2015 Revenue

Share:

Xtant Medical announced preliminary consolidated pro forma 2015 revenue in the range of ~US $86.4MM to $86.6MM, an increase of up to +11.3% from pro forma 2014, and a 4Q15 revenue of range of ~$22.0MM to $22.2MM, increasing up to +13.8% vs. 4Q14. 

Source: Xtant Medical Holdings, Inc.

Created from a merger of Bacterin with X-spine, Xtant Medical was one of several companies that altered the spinal landscape in 2015